Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.coi.2014.03.004 http://scihub22266oqcxt.onion/10.1016/j.coi.2014.03.004 C4118594!4118594!24762410     free     free     free       Curr+Opin+Immunol 2014 ; 28 (ä): 102-6 Nephropedia Template TP {{tp|p=24762410|t=2014. Interleukin 33: A Switch-Hitting Cytokine |pdf=|usr=}}{{24762410}} gab.com Text Interleukin 33: A Switch-Hitting Cytokine JO: Curr Opin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=24762410 #FOAvip For many years IL-33 has been widely studied in the context of T helper type 2 (TH2)-driven inflammatory disorders. Interestingly, IL-33 has now emerged as a cytokine with a plethora of pleiotropic properties. Depending on the immune cells targeted by IL-33, it is reported to not only promote TH2 immunity, but also to induce T helper type 1 (TH1) immunity. Furthermore, recent studies have revealed that IL-33 can activate CD8+ T cells. These new studies provide evidence for its beneficial role in antiviral and antitumor immunity. Here we review the evidence of IL-33 to drive protective T cell immunity plus its potential use as an adjuvant in vaccination and tumor therapy. Twit Text FOAVip Interleukin 33: A Switch-Hitting Cytokine ????Curr Opin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=24762410 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24762410 #FOAvip English Wikipedia <ref>{{Cite pmid|24762410}}</ref> Interleukin 33: A Switch-Hitting Cytokine #MMPMID24762410 Villarreal DO; Weiner DB Curr Opin Immunol 2014[Jun]; 28 (ä): 102-6 PMID24762410show ga For many years IL-33 has been widely studied in the context of T helper type 2 (TH2)-driven inflammatory disorders. Interestingly, IL-33 has now emerged as a cytokine with a plethora of pleiotropic properties. Depending on the immune cells targeted by IL-33, it is reported to not only promote TH2 immunity, but also to induce T helper type 1 (TH1) immunity. Furthermore, recent studies have revealed that IL-33 can activate CD8+ T cells. These new studies provide evidence for its beneficial role in antiviral and antitumor immunity. Here we review the evidence of IL-33 to drive protective T cell immunity plus its potential use as an adjuvant in vaccination and tumor therapy. äInterleukin 33: A Switch-Hitting Cytokine (epmc).pdf DeepDyve Pubget Overpricing